Ladenburg Thalmann Recent News
Taser Says VieVu's Legal Complaint Is 'Frivolous'
Taser Records Solid Top-Line Results, Though Margins Appear Arrested
Is There Still A Path Forward For The Novovax RSV Vaccine?
Ladenburg Thalmann On Biotech: Buy BioCryst, Albireo Shares
Myriad Genetics' Sell Thesis Is 'Largely Played Out'
Ladenburg On Biotech: Starts Achillion, Alnylam, Corcept, Trevana At Buy
Ladenburg Downgrades Cempra Following FDA's Complete Response Letter
Ladenburg Sets A New Buy Rating, $85 Target On Anadarko
Cuban Opportunity: President Trump Vs. Castro's Death
Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data
Repros Therapeutics Shares Rally Following Ladenburg Upgrade To Buy, Positive Data
XOMA Challenged With A 'Major Financing Overhang'
Taser's Top Line Was Impressive And Investors Responding In Part, But Competition Concerns Remain
Kindred Biosciences Is 'Setting The Pace In Animal Health Biologics'
Chesapeake's 4-Prong Strategy To Reduce Debt And Kick Start Growth
Ladenburg Thalmann Positive On TG Therapeutics Post Adjustments To GENUINE Study
Analyst Upgrades Capitala Finance On Dividend Alignment, De-Risked Portfolio
Taser Could Soon Be Facing Increased Price Competition
Ladenburg Thalmann Says Newly Merged Apple Hospitality REIT Could See Weakness Near Term
Ladenburg Thalmann Initiates Spire With A Neutral Rating, $69 Target
Spark Energy Is A 'Pure Play Competitive Retailer'
Medley's Growth Initiatives Are Already Priced Into The Stock
Metal-Mesh Sensors Are The Key To Uni-Pixel's Growth